This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CME Group to Launch Gold Futures Contract Amid Coronavirus Crisis
by Zacks Equity Research
CME Group (CME) unveils gold futures contract with expanded delivery options to settle the disruption in bullion trading.
Here's Why Investors Should Hold on to CME Group Stock Now
by Zacks Equity Research
CME Group (CME) is poised to grow, given its solid global presence and strong capital position.
Intercontinental Exchange to Close Trading Floors of NYSE
by Zacks Equity Research
Intercontinental Exchange (ICE) is set to shut The New York Stock Exchange trading floors due to coronavirus pandemic and shift to electronic trading.
Nasdaq to Close Its Trading Floor Amid Coronavirus Outbreak
by Zacks Equity Research
Nasdaq (NDAQ) is set to temporarily close its options trading floor in Philadelphia as a precautionary measure to contain the coronavirus outbreak.
Why Is CME (CME) Down 17.3% Since Last Earnings Report?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CME Group to Close Trading Floor Amid Coronavirus Outbreak
by Zacks Equity Research
CME Group (CME) is set to close its Chicago trading floor as a precautionary measure to reduce the spread of the coronavirus.
Solid Near-Term Outlook for Securities and Exchanges Industry
by Sapna Bagaria
The securities and exchange industry is poised to grow on mergers and acquisitions, product innovation as well as technological upgrade.
CME Group (CME) February Volumes Solid, Up Year Over Year
by Zacks Equity Research
CME Group's (CME) average daily volume for February increases on the back of better contribution by all its six product lines.
Intercontinental Exchange Reports Solid February Volume
by Zacks Equity Research
Intercontinental Exchange's (ICE) February volume reflects improved Financial ADV, Commodities ADV and Energy ADV.
Nasdaq (NDAQ) Reports Y/Y Increase in Volume for February
by Zacks Equity Research
Nasdaq's (NDAQ) February U.S. equity options volume increases 52.9% and European options and futures volume rises 35.8% year over year.
The Zacks Analyst Blog Highlights: Walmart, Pfizer, Charter Communications, Lockheed Martin and CME
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, Pfizer, Charter Communications, Lockheed Martin and CME
Get Your Mind Into Alpha Trading States with London's Top Coaches
by Kevin Cook
The trading game is so much tougher now with algos ripping and squeezing every edge -- except the ones you control.
Cboe Global's (CBOE) February Volume Rises Year Over Year
by Zacks Equity Research
Cboe Global's (CBOE) Options, Futures U.S. Equities and global forex volume reflect year-over-year increase in February. However, European Equities decline.
Top Stock Reports for Walmart, Pfizer & Charter Communications
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), Pfizer (PFE) and Charter Communications (CHTR).
After a Brutal Week, Hopeful Investors Turn Their Eyes to the Fed
by David Borun
The possibility of central bank action promise to lift equities after the biggest declines in over a decade.
CME Group (CME) in Focus: Stock Moves 5.7% Higher
by Zacks Equity Research
CME Group (CME) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
CME Group's (CME) Earnings Lag Estimates in Q4, Drop Y/Y
by Zacks Equity Research
CME Group's (CME) Q4 results disappoint with lower revenues and contracting Average Daily Volume.
5 Earnings All-Stars with Spectacular Charts
by Tracey Ryniec
These 5 companies have near perfect earnings surprise track records and their charts are a sight to behold.
CME Group (CME) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
CME Group's (CME) Q4 results are likely to reflect lower revenues from declining volumes.
Why Earnings Season Could Be Great for CME Group (CME)
by Zacks Equity Research
CME Group (CME) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Intercontinental Exchange (ICE) Q4 Earnings Meet, Rise Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) fourth-quarter earnings are hit by lower revenues.
CME Group (CME) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Cboe Global (CBOE) Q4 Earnings?
by Zacks Equity Research
Cboe Global's (CBOE) Q4 results might reflect a decline in revenues as well as trading volume.
Can CME (CME) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.